ELF3 Overexpression as Prognostic Biomarker for Recurrence of Stage II Colorectal Cancer

Background/Aim: Adjuvant chemotherapy for high-risk Stage II colorectal cancer (CRC) is weakly recommended; however, no consensus exists on “high-risk” definition. Prognostic biomarker identification is important for selecting patients with poor prognosis who may benefit from adjuvant chemotherapy....

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:In Vivo
Autores principales: TAKAOKA, AYUMI, ISHIKAWA, TOSHIAKI, OKAZAKI, SATOSHI, WATANABE, SHUICHI, MIYA, FUYUKI, TSUNODA, TATSUHIKO, KIKUCHI, AKIFUMI, YAMAUCHI, SHINICHI, MATSUYAMA, TAKATOSHI, TOKUNAGA, MASANORI, UETAKE, HIROYUKI, KINUGASA, YUSUKE
Formato: Artigo
Lenguaje:Inglês
Publicado: International Institute of Anticancer Research 2021
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7880722/
https://ncbi.nlm.nih.gov/pubmed/33402466
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.12248
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares